HUT52068A - Process for producing substituted hydroxyamines and pharmaceutical compositions containing them - Google Patents
Process for producing substituted hydroxyamines and pharmaceutical compositions containing themInfo
- Publication number
- HUT52068A HUT52068A HU886066A HU606688A HUT52068A HU T52068 A HUT52068 A HU T52068A HU 886066 A HU886066 A HU 886066A HU 606688 A HU606688 A HU 606688A HU T52068 A HUT52068 A HU T52068A
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- producing substituted
- hydroxyamines
- substituted hydroxyamines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
- C07C239/08—Hydroxylamino compounds or their ethers or esters
- C07C239/18—Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Indole Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19873739882 DE3739882A1 (de) | 1987-11-25 | 1987-11-25 | Substituierte hydroxylamine |
Publications (2)
Publication Number | Publication Date |
---|---|
HUT52068A true HUT52068A (en) | 1990-06-28 |
HU203722B HU203722B (en) | 1991-09-30 |
Family
ID=6341199
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU886066A HU203722B (en) | 1987-11-25 | 1988-11-25 | Process for producing substituted hydroxyamines and pharmaceutical compositions containing them |
Country Status (16)
Country | Link |
---|---|
US (2) | US4968681A (hu) |
EP (1) | EP0317845A3 (hu) |
JP (1) | JPH01165554A (hu) |
KR (1) | KR890008092A (hu) |
CN (1) | CN1033991A (hu) |
AU (1) | AU2590288A (hu) |
DD (1) | DD283603A5 (hu) |
DE (1) | DE3739882A1 (hu) |
DK (1) | DK656588A (hu) |
FI (1) | FI885427A (hu) |
HU (1) | HU203722B (hu) |
IL (1) | IL88446A0 (hu) |
NO (1) | NO885117L (hu) |
NZ (1) | NZ227031A (hu) |
PT (1) | PT89056A (hu) |
ZA (1) | ZA888789B (hu) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5354772A (en) * | 1982-11-22 | 1994-10-11 | Sandoz Pharm. Corp. | Indole analogs of mevalonolactone and derivatives thereof |
US6492413B2 (en) | 1993-01-15 | 2002-12-10 | G.D. Searle & Co. | 3.4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents |
CA2243199C (en) * | 1993-01-15 | 2005-08-02 | G.D. Searle & Co. | Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents |
US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
DE19513716A1 (de) * | 1995-02-01 | 1996-08-08 | Bayer Ag | Substituierte 2-Phenylindol-Derivate |
GB9411088D0 (en) * | 1994-06-03 | 1994-07-27 | Hoffmann La Roche | Hydroxylamine derivatives |
DK0946507T3 (da) * | 1996-12-10 | 2004-01-26 | Searle & Co | Substituerede pyrrolylforbindelser til behandling af inflammation |
US6355812B1 (en) | 1999-06-11 | 2002-03-12 | Orth-Mcneil Pharmaceutical, Inc. | Methods for the synthesis of dioxoalkanoic acid compounds |
US6699886B2 (en) * | 2001-05-31 | 2004-03-02 | Cellegy Pharmaceuticals, Inc. | Store operated calcium influx inhibitors and methods of use |
JP4359141B2 (ja) | 2001-07-13 | 2009-11-04 | アストラゼネカ・ユーケイ・リミテッド | アミノピリミジン化合物の製造 |
MXPA06006396A (es) * | 2004-01-20 | 2006-08-23 | Warner Lambert Co | Inhibidores de hmg-coa reductasa basados en imidazol. |
GB0428328D0 (en) * | 2004-12-24 | 2005-02-02 | Astrazeneca Uk Ltd | Chemical process |
CN112159333A (zh) * | 2020-10-15 | 2021-01-01 | 济宁康德瑞化工科技有限公司 | 一种双羟丙基羟胺的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3897465A (en) * | 1971-03-29 | 1975-07-29 | Airco Inc | Ethyl beta-(N-methylfurfurylamino) propionate |
US3760086A (en) * | 1971-03-29 | 1973-09-18 | Airco Inc | Tranquilizer |
BE848465A (fr) * | 1976-11-18 | 1977-03-16 | Stereo-isomeres de 1-(1'-benzyl-2' pyrryl)-2-disec.butylaminoethanols a activite analgesique et preparations pharmaceutiques qui les contiennent | |
US4231938A (en) * | 1979-06-15 | 1980-11-04 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
IL60219A (en) * | 1979-06-15 | 1985-05-31 | Merck & Co Inc | Hypocholesteremic fermentation products of the hmg-coa reductase inhibitor type,their preparation and pharmaceutical compositions containing them |
HU204253B (en) * | 1982-11-22 | 1991-12-30 | Sandoz Ag | Process for producing mevalonolactone analogues and derivatives and pharmaceutical compositions containing them |
EP0149588A3 (en) * | 1984-01-13 | 1986-05-07 | Sandoz Ag | N-(naphthyl-alkyl)-hydroxylamines |
US4595693A (en) * | 1984-06-04 | 1986-06-17 | Merck & Co., Inc. | Method of use of 2,5-diaryl tetrahydrofurans and analogs thereof as PAF-antagonists |
US4613610A (en) * | 1984-06-22 | 1986-09-23 | Sandoz Pharmaceuticals Corp. | Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives |
-
1987
- 1987-11-25 DE DE19873739882 patent/DE3739882A1/de not_active Withdrawn
-
1988
- 1988-11-11 EP EP88118817A patent/EP0317845A3/de not_active Withdrawn
- 1988-11-15 US US07/271,801 patent/US4968681A/en not_active Expired - Fee Related
- 1988-11-16 NO NO88885117A patent/NO885117L/no unknown
- 1988-11-22 NZ NZ227031A patent/NZ227031A/xx unknown
- 1988-11-22 IL IL88446A patent/IL88446A0/xx unknown
- 1988-11-22 JP JP63293737A patent/JPH01165554A/ja active Pending
- 1988-11-23 FI FI885427A patent/FI885427A/fi not_active Application Discontinuation
- 1988-11-23 DD DD88322085A patent/DD283603A5/de not_active IP Right Cessation
- 1988-11-23 PT PT89056A patent/PT89056A/pt not_active Application Discontinuation
- 1988-11-24 AU AU25902/88A patent/AU2590288A/en not_active Abandoned
- 1988-11-24 DK DK656588A patent/DK656588A/da not_active Application Discontinuation
- 1988-11-24 ZA ZA888789A patent/ZA888789B/xx unknown
- 1988-11-24 KR KR1019880015457A patent/KR890008092A/ko not_active Application Discontinuation
- 1988-11-25 HU HU886066A patent/HU203722B/hu not_active IP Right Cessation
- 1988-11-25 CN CN88108004A patent/CN1033991A/zh active Pending
-
1990
- 1990-03-08 US US07/490,206 patent/US5032590A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
KR890008092A (ko) | 1989-07-08 |
US5032590A (en) | 1991-07-16 |
US4968681A (en) | 1990-11-06 |
FI885427A (fi) | 1989-05-26 |
DK656588A (da) | 1989-05-26 |
DE3739882A1 (de) | 1989-06-08 |
NO885117L (no) | 1989-05-26 |
CN1033991A (zh) | 1989-07-19 |
FI885427A0 (fi) | 1988-11-23 |
EP0317845A2 (de) | 1989-05-31 |
JPH01165554A (ja) | 1989-06-29 |
NO885117D0 (no) | 1988-11-16 |
IL88446A0 (en) | 1989-06-30 |
DD283603A5 (de) | 1990-10-17 |
EP0317845A3 (de) | 1989-08-30 |
DK656588D0 (da) | 1988-11-24 |
HU203722B (en) | 1991-09-30 |
PT89056A (pt) | 1989-11-30 |
AU2590288A (en) | 1989-06-01 |
NZ227031A (en) | 1990-09-26 |
ZA888789B (en) | 1989-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT48267A (en) | Process for producing fluoro-citidin derivatives and pharmaceutical compositions containing them | |
HUT48900A (en) | Process for producing phosphoruus-containing squalene-synthetase inhibitores and pharmaceutical compositions containing them | |
HUT53644A (en) | Process for producing pharmaceutical nukleozides and pharmaceutical compositions containing them | |
HUT58326A (en) | Process for producing pipeidine derivatives and pharmaceutical compositions containing them | |
HUT45954A (en) | Process for producing tetrahydronaphtalene- and indanederivatives and pharmaceutical compositions containing them | |
HUT49316A (en) | Process for producing didehydro-d3-vitamine derivatives and pharmaceutical compositions containing them | |
HUT58304A (en) | Process for producing quinazolin-3-alkane-acids and pharmaceutical compositions containing them | |
HUT48887A (en) | Process for producing cyclopentenyl-purin derivatives and pharmaceutical compositions containing them | |
HUT50118A (en) | Process for producing new substituted lactames and pharmaceutical compositions containing them | |
HUT47278A (en) | Process for producing pyrrolo-benzimidazols and pharmaceutical compositions containing them | |
HUT56098A (en) | Process for producing azanaphtalenesultame derivatives and pharmaceutical compositions containing them | |
HUT59908A (en) | Process for producing benzazepine- and benzo-thiazepine derivatives and pharmaceutical compositions containing them | |
HUT50121A (en) | Process for producing piperidinyl-derivatives and pharmaceutical compositions containing them | |
HUT49317A (en) | Process for producing 16-dehydro-d3-vitamine derivatives and pharmaceutical compositions containing them | |
HUT47079A (en) | Process for producing n-amino-butyl-n-phenyl-aryl-amide derivatives and pharmaceutical compositions containing them | |
HUT50473A (en) | Process for producing imidazopyridazinones and pharmaceutical compositions comprising such compounds | |
HUT56078A (en) | Process for producing piridazine derivatives and pharmaceutical compositions containing them | |
HUT48870A (en) | Process for producing aminoalkoxyphenyl derivatives and pharmaceutical compositions comprising same | |
HU906358D0 (en) | Process for producing nukleosides and pharmaceutical compositions containing them | |
HUT52068A (en) | Process for producing substituted hydroxyamines and pharmaceutical compositions containing them | |
HUT53866A (en) | Process for producing new ammonium compounds and pharmaceutical compositions comprising such compounds | |
HUT43820A (en) | Process for producing n-(-2-((-2-hydroxy-phenyl-)(-phenyl-)-methylene-aminosquare )-ethyl-)-acetamide derivatives and pharmaceutical compositions containing them | |
HUT37148A (en) | Process for producing 8 alpha-acyl-amino-ergoline derivatives and pharmaceutical compositions containing them | |
HUT48244A (en) | Process for producing isoxazol-3-carbolin derivatives and pharmaceutical compositions containing them | |
HUT58739A (en) | Process for producing 3-oxo-3-/benzopyrano- or -thiopyrano-pyrazol-3-yl/-propionitril derivatives and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HMM4 | Cancellation of final prot. due to non-payment of fee |